- Home
- LTRN vs RDI Comparison
LTRN vs RDI Comparison
Compare LTRN & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- RDI
- Stock Information
- Founded
- LTRN 2013
- RDI 1937
- Country
- LTRN United States
- RDI United States
- Employees
- LTRN N/A
- RDI N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- RDI Movies/Entertainment
- Sector
- LTRN Health Care
- RDI Consumer Discretionary
- Exchange
- LTRN Nasdaq
- RDI Nasdaq
- Market Cap
- LTRN 33.7M
- RDI 32.3M
- IPO Year
- LTRN 2020
- RDI N/A
- Fundamental
- Price
- LTRN $4.48
- RDI $1.43
- Analyst Decision
- LTRN Hold
- RDI Hold
- Analyst Count
- LTRN 1
- RDI 1
- Target Price
- LTRN N/A
- RDI $2.40
- AVG Volume (30 Days)
- LTRN 69.9K
- RDI 157.9K
- Earning Date
- LTRN 03-17-2025
- RDI 11-14-2024
- Dividend Yield
- LTRN N/A
- RDI N/A
- EPS Growth
- LTRN N/A
- RDI N/A
- EPS
- LTRN N/A
- RDI N/A
- Revenue
- LTRN N/A
- RDI $197,270,000.00
- Revenue This Year
- LTRN N/A
- RDI N/A
- Revenue Next Year
- LTRN N/A
- RDI $14.40
- P/E Ratio
- LTRN N/A
- RDI N/A
- Revenue Growth
- LTRN N/A
- RDI N/A
- 52 Week Low
- LTRN $2.79
- RDI $1.22
- 52 Week High
- LTRN $11.99
- RDI $2.07
- Technical
- Relative Strength Index (RSI)
- LTRN 66.50
- RDI 51.96
- Support Level
- LTRN $3.48
- RDI $1.38
- Resistance Level
- LTRN $3.97
- RDI $1.50
- Average True Range (ATR)
- LTRN 0.44
- RDI 0.09
- MACD
- LTRN 0.06
- RDI 0.01
- Stochastic Oscillator
- LTRN 76.50
- RDI 71.43
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.